High-risk HPV-related squamous cell carcinoma in the temporal bone: a rare but noteworthy subtype
- PMID: 36705751
- DOI: 10.1007/s00428-023-03497-7
High-risk HPV-related squamous cell carcinoma in the temporal bone: a rare but noteworthy subtype
Abstract
High-risk human papillomavirus (HPV) is a risk factor for the development of several head and neck squamous cell carcinomas (SCCs). However, there have been few reports of high-risk HPV infection in temporal bone squamous cell carcinomas (TBSCCs), and thus the prevalence and clinicopathologic significance of high-risk HPV in TBSCCs are still unclear. We retrospectively collected 131 TBSCCs and analyzed them for transcriptionally active high-risk HPV infection using messenger RNA in situ hybridization; we also assessed the utility of p16-immunohistochemistry (IHC) and Rb-IHC to predict HPV infection. Eighteen (13.7%) of the 131 TBSCCs were positive for p16-IHC, and five of them were positive for high-risk HPV infection (the estimated high-risk HPV positivity rate was 3.8% [5/131]). Interestingly, all five HPV-positive patients were male and had TBSCC on the right side. In the p16-IHC+/HPV+ cases (n = 5), the Rb-IHC showed a partial loss pattern (n = 4) or complete loss pattern (n = 1). In contrast, all p16-IHC-negative cases (n = 113) showed an Rb-IHC preserved pattern. The positive predictive value (PPV) of p16-IHC positivity for high-risk HPV infection was low at 27.8%, while the combination of p16-IHC+/Rb-IHC partial loss pattern showed excellent reliability with a PPV of 100%. The prognostic significance of high-risk HPV infection remained unclear. High-risk HPV-related TBSCC is an extremely rare but noteworthy subtype.
Keywords: Human papillomavirus; Rb; Squamous cell carcinoma; Temporal bone; p16.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Seligman KL, Sun DQ, Ten Eyck PP, Schularick NM, Hansen MR (2020) Temporal bone carcinoma: treatment patterns and survival. Laryngoscope 130:E11-20. https://doi.org/10.1002/lary.27877 - DOI - PubMed
-
- Moody SA, Hirsch BE, Myers EN (2000) Squamous cell carcinoma of the external auditory canal: an evaluation of a staging system. Am J Otol 21:582–588 - PubMed
-
- Allanson BM, Low TH, Clark JR, Gupta R (2018) Squamous cell carcinoma of the external auditory canal and temporal bone: an update. Head Neck Pathol 12:407–418. https://doi.org/10.1007/s12105-018-0908-4 - DOI - PubMed - PMC
-
- Yin M, Ishikawa K, Honda K, Arakawa T, Harabuchi Y, Nagabashi T, Fukuda S, Taira A, Himi T, Nakamura N, Tanaka K, Ichinohe M, Shinkawa H, Nakada Y, Sato H, Shiga K, Kobayashi T, Watanabe T, Aoyagi M, Ogawa H, Omori K (2006) Analysis of 95 cases of squamous cell carcinoma of the external and middle ear. Auris Nasus Larynx 33:251–257. https://doi.org/10.1016/j.anl.2005.11.012 - DOI - PubMed
-
- Sato K, Komune N, Hongo T, Koike K, Niida A, Uchi R, Noda T, Kogo R, Matsumoto N, Yamamoto H, Masuda M, Oda Y, Mimori K, Nakagawa T (2020) Genetic landscape of external auditory canal squamous cell carcinoma. Cancer Sci 111:3010–3019. https://doi.org/10.1111/cas.14515 - DOI - PubMed - PMC
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical